Next-generation everolimus-eluting coronary stent gains US approval
The FDA has approved a next-generation everolimus-eluting coronary stent for the treatment of coronary artery disease. The stent (Xience Prime, Abbott) is indicated for the improvement of coronary artery luminal diameter in patients with symptomatic ...
Abbott's XIENCE PRIME Stent Wins US Clearance
Abbott to Present New Data for Key Vascular Products at TCT 2011
FDA Approves Abbott's Xience Prime Coronary Stent